NeuroMetrix Plans Strategic Options To Promote Growth, Maximize Shareholder Value; Stock Drops

On Tuesday, medical device company NeuroMetrix, Inc. (NURO) said that it has reviewed strategic options for the growth of its Quell neuromodulation and DPNCheck neurodiagnostic businesses with maximum shareholder value.

Related Keywords

Shai Gozani ,Nasdaq ,Neurometrix Inc ,Ladenburg Thalmann Co ,Medicare Advantage ,Ladenburg Thalmann ,